期刊文献+

左乙拉西坦及其衍生物的合成 被引量:9

Synthesis of levetiracetam and its derivatives
下载PDF
导出
摘要 目的:探讨左乙拉西坦及其衍生物的制备方法。方法:以2-吡咯烷酮为起始原料,经成盐和取代得外消旋中间体(±)-α-乙基-(2-氧-1-吡咯烷基)乙酸(1),再以R-α-苯乙胺为拆分剂,得中间体(S)-α-乙基-(2-氧-1-吡咯烷基)乙酸(3),3分别与相应的氨、胺或醇发生酰化反应,得到左乙拉西坦及其衍生物。结果:得到左乙拉西坦及其9个衍生物,8个作者未见文献报道。经红外光谱1、HNMR或元素分析认定结构正确。结论:本合成工艺有助于工业化生产,9个目标化合物对提高药物促智作用,降低不良反应能起到积极作用。 Objective: To investigate synthesis of levetiracetan and its derivatives. Methods: The racemic( + )-α-ethyl-(2-oxo-1-pyrrolidinyl)acetic acid (1) was obtained via the salt forming and substitution of 2-pyrrolidone. The intermediate (S) -α-ethyl-(2-oxo-1-pyrrolidinyl) acetic acid ( 3 ) was obtained from the racemic 1 by chemical resolution with an optically active (R)-α-methyl-benzylamine. The intermediate 3 was treated with corresponding amine or alcohol to provide levetiracetan and its 9 analogs. Results: Levetiracetan and its 9 derivatives, where 8 were new compounds, were obtained, and their structures were confirmed by IR. ^1HNMR or elemental analyses. Conclusion : The preparation method of levetiracetam is good to its industrialization and the 9 analogs are useful for searching more effective lead compound.
出处 《中国新药杂志》 CAS CSCD 北大核心 2007年第11期860-864,共5页 Chinese Journal of New Drugs
关键词 左乙拉西坦 抗癫痫 药物合成 levetiracetam anti-epilepsia synthesis
  • 相关文献

参考文献12

  • 1罗湘冀.左乙拉西坦的合成[J].药学进展,2004,28(9):413-417. 被引量:11
  • 2施安国,费艳秋,王平全.抗癫痫新药左乙拉西坦[J].中国新药杂志,2000,9(11):742-744. 被引量:15
  • 3NICOLAUS BJR.Chemistry and pharmacology of nootropies[J].Drug Develop Res,1992,2(5):463-464.
  • 4张万金,王尔华.α-乙基-[(2-氧)-1-]吡咯烷乙酰胺衍生物的合成[J].广东药学院学报,2000,16(4):263-264. 被引量:2
  • 5耿国银,武俊莲,李永安,郭四虎.脑复康合成工艺研究[J].应用化工,2001,30(3):23-24. 被引量:4
  • 6UCB Societe Anonyme.(S)-alpha-ethyl-2-oxo-1-pyrrolidine acetamide:USP,4,696,943[P].1985-05-14.
  • 7UCB Societe Anonyme.Pharmacologically active N-substituted lactams:Belgium Patent,762728[P].1971-08-10.
  • 8MACHIDA M,OYADOMARI S,TAKECHI H,et al.Photocyclization of succinimide derivatives with amido group in side chains synthesis of tricyclie pyrrolo[1,2-a]pyrazine ring systems[J].Heterocycles,1982,19(11):2057-2060.
  • 9GUDASHEVA TA,OSTROVSKAYS RU,TROFIMOV SS,et al.Peptide analogs of piracetam as ligands of putative nootropic receptors[J].Khim Farm Zh,1985,19(11):1322-1329.
  • 10HASKEL TH,HUTT MP JR,NICOLAIDES ED.Antibacterial amide compounds:US Patent,4,267,180[P].1981-05-12.

二级参考文献9

  • 1周仁兴,邵立人.吡咯烷酮乙酰胺的合成[J].医药工业,1981(2):3-4. 被引量:13
  • 2Mukta D, Greg L P. Levetiracetam: A Review of its Adjunctive Use in the Management of Partial Onset Weizures[J]. Drugs, 2000, 60 (4): 871 -893.
  • 3Alma J G, Michel N. Ucb L059, a novel anti-convulsant drug: pharmacological profile in animals[J]. Eru J pharmacol, 1992,222:193-203.
  • 4Jean G, Jean-Pierre G, Guy B. (S)- Alpha- Ethyl-2- oxo-1- Pyrrolidineacetamide[P].US:4696943,1987-9-29.
  • 5Eric C, Genevieve M, Jean-Pierre G, et al. The preparation of (S)-Alpha-Ethyl-2-oxo-1-Pyrrolidineacetamide[P]. GB:2225322,1990-5-30.
  • 6Tooru F, Jean-Pierre C, Emile C, et al. Process for the preparation of levetiracetam[P].US:6107492,2000-8-22.
  • 7Surtees J, Marmon V, Differding E, et al. 2-Oxo-1-pyrroliding derivatives, process for preparing them and their uses[P].WO:0164637 A1, 2001-9-7.
  • 8Ates C, Surtees J, Burteau A-C, et al. Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues[P].WO:03014080 A2,2003-2-20.
  • 9邓艳良.吡乙酰胺合成路线图解[J].中国医药工业杂志,1991,22(4):186-187. 被引量:4

共引文献26

同被引文献56

引证文献9

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部